FDA recalls MG217 eczema cream after staph contamination
The FDA says one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream is being recalled nationwide because it was contaminated with Staphylococcus aureus. People with weakened immune systems or damaged skin may face the greatest risk, and anyone who used the affected tube should watch for signs of infection and seek care promptly if symptoms appear.
The FDA says one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream is being recalled nationwide after testing found contamination with Staphylococcus aureus. The agency says the affected product is a 6-ounce tube from lot 1024088, with an expiration date of November 2026.
Most people who used the cream will not develop a serious problem, but the recall matters because staph bacteria can cause skin infections and, in some cases, more serious illness. People with weakened immune systems or damaged skin may face higher risk.
What FDA recalled and why
According to the FDA, Pharmacal is recalling one lot of the eczema cream because it was contaminated with Staphylococcus aureus. The agency says the product was distributed nationwide through wholesale, retail, and internet channels.
The FDA also says the company had not received reports of adverse events related to the recall at the time of the notice.
Which lot is affected
The recall covers MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6-ounce tube, product code 5106, UPC 012277051067, lot 1024088, expiration date November 2026. The lot number is located in the crimped end of the tube, according to the FDA notice.
Why Staphylococcus aureus contamination matters
CDC says Staphylococcus aureus, or staph, is a common germ found on the skin and in the nose of many healthy people. It does not always cause illness, but it can lead to infections if it gets into broken skin or deeper tissues.
In some cases, staph infections can spread beyond the skin and lead to bloodstream infection, sepsis, endocarditis, bone infection, or pneumonia. The risk is higher for people with chronic conditions, weakened immune systems, or compromised skin, such as wounds, burns, or skin disorders, which is consistent with the FDA warning.
Who faces higher risk
People may be more vulnerable if they have eczema or other skin conditions that weaken the skin barrier, open wounds, burns, recent surgery, implanted medical devices, diabetes, cancer, or other causes of immune suppression. CDC also notes that more serious staph infections are more likely in people with certain chronic illnesses or weakened immune systems.
Symptoms to watch for
Staph skin infections can look like pimples, boils, redness, swelling, warmth, tenderness, or pus. More serious infection can bring fever, spreading redness, worsening pain, drainage, or symptoms that suggest the infection is moving beyond the skin.
Seek urgent care right away if there are signs of rapid worsening, severe pain, confusion, trouble breathing, fainting, or other symptoms that could signal sepsis or another emergency.
What to do now if you used the cream
If you have the recalled tube, stop using that specific product and follow the FDA and manufacturer instructions for disposal or return. If you already applied it, monitor the skin and your overall health closely for signs of infection.
If symptoms develop, contact a clinician or pharmacist promptly. Do not assume every rash or sore is caused by the recall, but do not ignore new redness, pus, spreading swelling, fever, or a wound that seems to be getting worse.
What is still unknown
The FDA notice does not say how the contamination occurred, whether any other lots are affected, or whether the recall will expand. It also does not mean every person who used the cream will become ill.
For families and caregivers, the practical step is to check the tube for the lot number, avoid using the recalled product, and keep an eye out for skin changes in anyone who may be more medically fragile.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
